Article
Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment
29 Mar 2023
Abstract excerpt
Colorectal cancer (CRC) is the third most prevalent one in the world among the most common malignant tumors. Numerous studies have shown that butyrate has demonstrated promise as an antitumor agent in a variety of human cancer types. However, butyrate remains understudied in CRC tumorigenesis and progression. In this study, we explored therapeutic strategies to treat CRC by examining the role of butyrate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
